ERBB2 and breast cancer: While AQP3 overexpression in early breast cancer patients was shown to be associated with a worse prognosis in patients with the HER2-overexpressing phenotype [22], AQP1 and AQP5 were reported as independent prognostic markers of survival for breast cancer patients [23–25].